Cobionix Corp., a Canada-based medical robotics company, raised $3 million led by TitletownTech, Lions Investment, and Dr. Paul McBeth.
The funding will support the development of their robotic platform, Codi, designed for autonomous diagnostic ultrasound procedures in remote locations.
Codi is described as a versatile medical collaborative robotic platform adaptable for various patient-facing tasks through simple tool changes.
The company plans to launch pilot programs for Codi in August, with a commercial launch in the U.S. scheduled for 2026.